Delivery Order SPE2DB24D1034-SPE2DB25FWEY1
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,130.81 on July 31, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract has an ultimate completion date of August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $17,796.50 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order valued at $56,505.05 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $11,472.94 delivery order to AmerisourceBergen Drug Corp for 90-count supplies of Jardiance 25 mg tablets, a diabetes medication. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure, with an ultimate completion date of July 28, 2025. AmerisourceBergen will perform the delivery from its corporate office in Conshohocken, Pennsylvania, where the company maintains its primary headquarters as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) with a ceiling value of $2,858.49. This firm fixed-price delivery order is set to be completed by August 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive, competitively awarded contract under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $6,475.44. This competitively awarded, firm fixed-price delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and specifies...
- The Defense Logistics Agency awarded a delivery order valued at $15,404.48 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-competitive delivery order utilizes firm fixed pricing and is sourced from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement to support federal healthcare operations....
- The Defense Logistics Agency awarded a delivery order valued at $40,271.47 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on August 4, 2025, with completion due by August 5, 2025. This firm fixed-price, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999.99 million through December 2026. The product will be delivered to...
- The Defense Logistics Agency awarded a $25,383.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded contract, which carries no set-aside designation, is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $35,131.14 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price delivery order represents a direct supply of the diabetes medication to support federal medical procurement needs. The contract was competitively awarded with no set-aside designation, and performance will be executed from AmerisourceBergen's...
- SPE2DB24D1034Indefinite Delivery Contract
- SPE2DB24D1034-SPE2DB25FWEY1Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $22,096.58 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units). This non-competitive, firm fixed-price delivery order was awarded on August 8, 2025, with an ultimate completion date of August 11, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total potential value of $999,999,999 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal vendor, leverages its extensive prime indefinite delivery vehicle with DLA to supply a comprehensive range of pharmaceutical products and medical supplies supporting military and veteran healthcare systems. The company's SPE2DX contract enables delivery orders such as this one across multiple therapeutic domains, including diabetes medications, neurological treatments, pain management pharmaceuticals, and specialized medical supplies. As AmerisourceBergen competes for the upcoming DLA Troop Support Pharmaceutical Prime Vendor Global Program Generation V contracts—which DLA intends to award to multiple contractors by region—the company continues to fulfill critical pharmaceutical supply needs for the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.1k | 8/8/25 |